Answers are grounded in this paper and cite their sources.
OBJECTIVE: Evaluation of the efficacy of a patented, compound herbal preparation (CHP) in improving attention, cognition, and impulse control in children with ADHD. DESIGN: A randomized, double-blind, placebo-controlled trial. SETTING: University-affiliated tertiary medical center. PARTICIPANTS: 120 children newly diagnosed with ADHD, meeting DSM-IV criteria. INTERVENTION: Random assignment to the herbal treatment group (n = 80) or control group (placebo; n = 40); 73 patients in the treatment group (91%) and 19 in the control group (48%) completed the 4-month trial. OUTCOME MEASURE: Test of Variables of Attention (TOVA) administered before and after the treatment period; overall score and 4 subscales. RESULTS: The treatment group showed substantial, statistically significant improvement in the 4 subscales and overall TOVA scores, compared with no improvement in the control group, which persisted in an intention-to-treat analysis. CONCLUSIONS: The well-tolerated CHP demonstrated improved attention, cognition, and impulse control in the intervention group, indicating promise for ADHD treatment in children.
No takes yet. Share an insight, caveat, or question.
Katz et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: